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Characteristics of cannabis cultivation in
New Zealand and Israel
Chris Wilkins, Sharon Sznitman, Tom Decorte, Pekka Hakkarainen and Simon Lenton
Abstract
Purpose – The purpose of this paper is to explore the characteristics of small-scale cannabis cultivation in
New Zealand and Israel.
Design/methodology/approach – An online survey of predominantly small-scale cannabis cultivators had
previously been conducted in 11 countries in 2012/2013. The same core online survey was subsequently
conducted in New Zealand and Israel in 2016/2017, and comparisons made with the original 11 countries.
Findings – Only around one third of the New Zealand and Israeli cannabis growers had sold cannabis, and
the majority of these did so only to cover the costs of cultivation. The median number of cannabis plants
cultivated per crop by the New Zealand and Israeli growers was five and two, respectively. The leading
reasons provided for growing cannabis by both the New Zealand and Israeli growers were to provide
cannabis for personal use and to share with others. A higher proportion of New Zealand than Israeli growers
reported growing cannabis for medicinal reasons. A total of 16 per cent of the New Zealand and 17 per cent
of Israeli growers had come into contact with the police due to their cannabis cultivation. The findings suggest
small-scale cannabis cultivation in New Zealand and Israel is largely a means of “social supply” of cannabis,
and this is consistent with the findings from the original 11 countries. The higher incidence of growing
cannabis for medicinal purposes in New Zealand may reflect the limited official access to medical cannabis.
Significant minorities of small-scale cannabis growers in both countries had contact with police, putting them
at risk of the negative consequences of a criminal conviction.
Originality/value – To date, the research into cannabis cultivation has largely consisted of studies of individual
countries. However, given the global popularity of cannabis use, and the recent spread of cannabis cultivation
to countries that traditionally have not produced cannabis, via utilisation of indoor growing techniques, there is
now a strong case for international comparative research. Following the success of the surveys in the original
11 countries, New Zealand and Israeli members of the Global Cannabis Cultivation Research Consortium
international collaboration chose to undertake surveys in their own countries in 2016/2017.
Keywords New Zealand, Israel, Cannabis cultivation, Cannabis, Online survey, Cannabis policy
Paper type Research paper
Introduction
Until recently research into cannabis cultivation has largely consisted of studies of individual
countries (e.g. Nguyen and Bouchard, 2010; Potter and Dann, 2005; Weisheit, 1991; Belackova
and Vaccaro, 2013; Belackova et al., 2015; Bouchard, 2007; Bouchard et al., 2009; Decorte,
2008, 2010; Douglas and Sullivan, 2013; Hakkarainen, Frank, Perälä and Dahl, 2011;
Hakkarainen, Perälä and Metso, 2011; Hammersvik et al., 2012; Malm, 2006; Plecas et al.,
2005; Potter, 2010; Weisheit, 1992; Wilkins and Casswell, 2003). However, given the global
popularity of cannabis use, and the recent spread of cannabis cultivation to countries that
traditionally have not produced cannabis, via the utilisation of indoor growing techniques, there is
now a strong case for international comparative research (INCB, 2013, para. 69, Potter et al.,
2011). This was the rationale for setting up of the Global Cannabis Cultivation Research
Consortium (GCCRC) and the undertaking of a series of online surveys of predominately small-
scale cannabis cultivators in 11 different countries in 2012/13, using the same methodology and
questionnaire (i.e. Canada, USA, Belgium, Denmark, Finland, Germany, Austria, German-speaking
Switzerland, the Netherlands, UK, and Australia) (Potter et al., 2015; Barratt et al., 2015).
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These surveys found a great deal of similarity in small-scale cannabis growing across countries in
terms of the demographic characteristics of growers, methods and scale of growing operations,
reasons for growing cannabis, use of cannabis and other drugs, participation in cannabis and
other drug markets, and contact with the criminal justice system (Potter et al., 2015). A majority of
the small-scale cannabis cultivators were primarily motivated by reasons other than making
money from cannabis supply, and had minimal involvement in drug dealing or other criminal
activities (Potter et al., 2015).
Following the success of the surveys in the original 11 countries, New Zealand and Israeli
members of the GCCRC international collaboration chose to undertake surveys in their
own countries in 2016/2017. New Zealand and Israel both have relatively small populations
(i.e. 4.8 and 8.8 million), but are located in different parts of the world, with different climatic and
growing conditions, and also different legal and political regimes. While the recreational use of
cannabis is illegal in both countries, Israel has a long-standing and well-developed medical
cannabis programme. There are eight legal medical cannabis growers in Israel. These are all
licenced private companies who supply cannabis to approximately 28,000 licenced medical
cannabis patients. Annual rates of recreational cannabis use have traditionally been relatively low
in Israel, but recent data suggest that recreational use has increased significantly in recent years
(Harel-Fisch, 2017). In contrast, in New Zealand, there is only limited official access to medicinal
cannabis, and a long history of fairly high rates of recreational cannabis use by international
standards (Wilkins, 2016; Wilkins and Sweetsur, 2008). The most recent New Zealand
national survey found 11.6 per cent of the adult population reported using cannabis in the past
year, and this had not significantly changed over the previous 10 years (Ministry of Health, 2018).
This paper reports the findings from the New Zealand and Israeli surveys, and discusses
differences and similarities with the findings from the surveys of the 11 original countries.
Methods
The methodology used by GCCRC has been described in some detail elsewhere (Barratt et al.,
2012; Barratt et al., 2015; Decorte et al., 2011). Briefly, following online surveys of cannabis
cultivators in Belgium (Decorte, 2010) and Denmark and Finland (Hakkarainen, Frank, Perälä and
Dahl, 2011), the GCCRC developed a standardised online survey to allow comparisons between
countries who subsequently conducted the online survey (Decorte et al., 2012). The resulting 26
item core ICCQ includes modules on: experiences with growing cannabis; methods and scale of
growing operations; reasons for growing; personal use of cannabis and other drugs; participation
in cannabis and other drug markets; contact with the criminal justice system; involvement in other
(non-drug-related) illegal activities; and demographic characteristics.
The online surveys were promoted in participating countries via a range of channels including the
GCCRC project website (www.worldwideweed.nl), Twitter™, online forums, Facebook™ groups,
mainstream media, alternative media, flyers, street press, festivals and grow shops. Many of
these strategies were international, leading people to the project website (www.worldwideweed.nl)
where they could then choose the survey and language associated with their country of residence
(see Barratt et al., 2015). In New Zealand, the survey was promoted in close collaboration with
National Organisation for the Reform ofMarijuana Laws (NORML) New Zealand who posted the link
to the survey on their website along with background information about the research and GCCRC.
Flyers were also distributed at cannabis protest events (e.g. “J day”). In Israel, the survey was
promoted by the moderator of the Israeli Cannabis Magazine (www. קנאביס .com), themost popular
online cannabis information source in Hebrew. No financial incentive was provided to those who
participated in the surveys to reduce the likelihood of fraudulent responses.
Selecting eligible samples
Not all respondents to the surveys have been included in the data presented here. Three rules
were used to determine eligible samples:
1. Respondents answered three eligibility questions at the beginning of the questionnaire.
These were: aged 18 years or over; resided in the country of the survey; and reported that
they had grown cannabis at least once.






























2. Q3 of the ICCQ asked “how long ago did you last grow cannabis?” In order to reflect only recent
trends in growing, we have excluded the participants who reported last growing cannabis more
than five years ago and those who did not know, refused or skipped this question.
3. The samples reported here completed at least half of the core ICCQ questions. (i.e. 14 or
more of the 26 core ICCQ questions).
After applying these rules, we are left with a final sample of 202 respondents from New Zealand
and 367 respondents from Israel. A total of 6,530 respondents completed the survey from the
original 11 countries (i.e. Canada¼ 63, USA¼ 645, Belgium¼ 1,065, Denmark¼ 814,
Finland¼ 1,179, Germany¼ 1,348, Austria¼ 129, German-speaking Switzerland¼ 101, the
Netherlands¼ 277, UK¼ 418, and Australia¼ 491).
Findings
Demographics characteristics
In total, 95 per cent of the Israeli respondents were male. (Table I). This is broadly consistent with
the approximately 90 per cent male respondents in the original 11 countries In contrast,
New Zealand had a noticeably higher proportion of female respondents (i.e. 21 per cent)
The median age of the New Zealand sample was 38 years old, compared to 26 years for the
Israeli sample. The New Zealand sample was older than even the Australian (35 years), Danish
(31 years), Dutch (32 years) and British (33 years) respondents. The Israeli sample was younger
and closer to the Swiss (25 years), Austrian (25 years), German (26 years), Finnish (26 years),
Canadian (25 years), US (26 years) and Belgian (26 years) respondents. These differences in the
age of samples may reflect differences in the recruitment strategies for each survey. For example,
the Belgian, German, Austrian and Swiss surveys recruited a higher proportion of students.
Respondents from both New Zealand and Israel were much more likely to be in some form of
employment than receiving social welfare benefits, and this is broadly consistent with the patterns
of employment found in the other 11 counties.
Growing experiences
The Israeli growers were relatively inexperienced at cannabis cultivation compared to many of the
other country samples, with only 6 per cent reporting they had grown 11 or more cannabis crops
(Table II). The next most inexperienced groups of growers were from Belgium, where 11 per cent
Table I Gender and age
New Zealand Israel 11 combined
Gender (%) Male 79 95 92
Female 21 5 8
Total n 171 274 6,200
Age Median 38 26 27
Range 18-81 18-74 18-86
Total n 170 280 6,228
Employment status (%a) Full-time work 47 51 41
Part-time or casual work 11 20 12
Self-employed – 22 12
Student (any type) 11 20 27
Unemployed – looking for work 10 7 7
Benefits/pension/disability 9 1 6
Home duties 9 1 2
Retired 6 – 3
Not seeking work – 1 3
Total n 159 292 4,679
Note: aRespondents invited to tick more than one option; columns can total more than 100 per cent






























had grown 11 or more crops. In contrast, the New Zealand sample of growers was particularly
experienced, with 34 per cent having grown 11 or more crops. Only the Danish, British and
Australian respondents reported similar levels of experience (i.e. 30, 31 and 33 per cent,
respectively). This may reflect the older age of respondents from these countries. The majority of
respondents from all countries reported successfully cultivating cannabis on their first attempt,
including 60 per cent of the New Zealand and 63 per cent of the Israeli growers.
Growing method and scale
Only approximately one third of New Zealanders reported growing cannabis indoors
(34 per cent), similar to levels reported in Belgium (34 per cent), Australia (27 per cent),
Denmark (39 per cent), the Netherlands (33 per cent) and Switzerland (32 per cent). In contrast,
respondents from other countries was much more likely to grow indoors including the USA
(80 per cent), UK (76 per cent), Canada (68 per cent) and Finland (62 per cent) (Table III). Israel
was somewhat in the middle of these two extremes, with 53 per cent reporting growing indoors.
Many respondents in each country reported some combination of indoor and outdoor growing.
Table II Number of crops grown and attempts before first successful grow
New Zealand Israel c11 combined
How many crops ever grown? (%a) I have not yet harvested
my first crop
6 2 7
1 crop 8 33 15
2-5 crops 37 47 42
6-10 crops 15 12 17
11-20 crops 11 3 10
21-50 crops 11 1 6
More than 50 crops 12 2 4
Total n 198 316 6,271
How many times did you fail before you
succeeded in getting a crop? (%a)
Succeeded first time 60 63 67
1 attempt 16 21 16
2 attempts 10 10 7
3 attempts 4 3 2
4 attempts 2 1 1
5 or more attempts 2 1 1
I have not yet harvested
my first crop
6 2 7
Total n 194 360 6,303
Note: aColumns can total more than 100 per cent due to rounding
Table III Location, size of crop and yield per plant
New Zealand Israel 11 combined
Do you typically grow indoors or outdoors?(%a) Indoors 34 53 49
Outdoors 25 24 20
Both indoor and outdoor in the same growing period 27 14 21
Seedling grown indoors, then planted outdoors 14 9 10
Total n 198 328 5,811
Number of mature plants per cropb Median 5 2 5
Range 1-100+ 0-101 1-100+
Total n 193 341 5,275
Typical yield per plant (ounces) Median 3 1.4 1.4
Total n 98 304 4,174
Notes: aThe percentage may not total 100 due to rounding; bonly respondents who have harvested at least one crop and reported growing one or
more mature plants per crop were included in this analysis. This table only shows those respondents who have harvested at least one crop






























The New Zealand and Israeli growers reported fairly low numbers of mature cannabis plants per
crop (i.e. five and two, respectively), and this was broadly consistent with the other 11 countries.
The highest median number of plants reported per crop was only nine plants, as reported in
Austria and Switzerland.
The median yield (i.e. “usable dried cannabis”) reported per plant was three ounces among the
New Zealand growers and 1.4 ounces among the Israeli growers. The overall median yield per
plant for the original 11 countries was 1.4 ounces. The Australian (3.0 ounces) and, to a lesser
extent, Dutch (2.1 ounces) growers reported higher plant yields, similar to the New Zealand
growers. The higher plant yields likely reflect a range of factors including specialised cannabis
horticulture knowledge, availability of high growth cannabis strains, and exceptional climatic and
geographical conditions for cannabis cultivation. In general, the outdoor cultivation of cannabis
tends to produce plants with higher yields (Potter et al., 2015).
Reasons for growing
Providing a “supply of cannabis for personal use”, “lower cost”, and to “avoid contact with the
illegal drugs market” were some of the most popular reasons reported for growing among both
New Zealand and Israel respondents, and indeed among the other 11 countries (Table IV ). Fairly
high proportions of New Zealand respondents reported growing cannabis for “(own) medical
reason” (53 per cent) and “to provide others with cannabis for medical reasons” (33 per cent).
In contrast, these were less common reasons provided by Israeli growers for growing cannabis
(33 and 10 per cent, respectively). The combined original 11 countries were more like to grow
cannabis for their own and others medical reasons (44 and 18 per cent, respectively) than the
Israel sample, but still did not reach the levels reported by the New Zealand grower sample.
Only 10 per cent of the New Zealand respondents and 6 per cent of the Israeli respondents
reported growing cannabis so they would sell it. Similarly, only 11 per cent of the respondents from
the original 11 countries surveyed chose “so I can sell it” as a reason for growing cannabis.
Market participation
Unsurprisingly, the vast majority of New Zealand (87 per cent) and Israeli (99 per cent) growers
reported consuming at least part of their crops for personal cannabis use, and this resembles the
Table IV Reasons for growing cannabis
New Zealand Israel 11 combined
It provides me with cannabis for personal use 94 83 84
I get pleasure from growing cannabis 78 67 83
Cheaper than buying cannabis 78 79 75
To avoid contact with criminals 65 66 72
The cannabis I grow is healthier than the cannabis I buy 54 49 68
Because the plant is beautiful 64 50 48
To provide myself with cannabis for medical reasons 53 33 44
I wanted to see whether I could grow it 43 42 43
The cannabis I grow is a more consistent product than the cannabis I can buy 45 27 41
So I can share it/give it to my friends and acquaintances 51 18 40
For activist reasons (e.g. ecological ideology, fair trade) 27 27 38
I can flush the cannabis I grow to remove chemical residue 33 25 33
Because the plant is easy to take care of 42 20 32
Growing your own cannabis is not as risky as buying it 43 28 30
Because it is easier to grow than to buy 43 17 29
The cannabis I can grow is stronger than the cannabis I can buy 28 25 23
To provide others with cannabis for medical reasons 33 10 18
The cannabis I can grow is milder than the cannabis I can buy 7 3 12
So I can sell it 10 6 11
Notes: Values cited are % of respondents choosing each reason. The question asked respondents to tick all options that applied to them






























reports from the original 11 countries (97 per cent) (Table V ). The relatively lower level of
New Zealand growers reporting consuming at least part of their own crop may be explained by
the higher proportion of New Zealand growers who reported they grew to provide cannabis for
the medicinal requirements of others. These growers may be solely focussed on supplying
cannabis for the medicinal needs of others and may not use cannabis themselves.
In total, 69 per cent of the New Zealand and 51 per cent of the Israeli growers also reported
sharing cannabis with others, and again this was consistent with the previous 11 countries
(71 per cent). New Zealand growers had a slightly higher level of swapping (30 per cent),
while Israel growers reported a lower level of swapping (9 per cent) compared to the other 11
countries (26 per cent).
Approximately three out of ten of both the New Zealand (31 per cent) and Israeli growers (27 per cent)
reported selling cannabis. However, the majority reported doing so to cover the costs of growing
(25 and 20 per cent, respectively) rather than for profit. The New Zealand respondents reported
relatively higher rates of selling for profit (20 per cent) than the Israeli respondents (15 per cent).
Similarly, 3 out of 10 of the respondents from the original 11 countries reported selling cannabis to
others, with the majority selling to cover the cost of growing rather than for profit.
Around two-thirds of New Zealand (68 per cent) and Israeli (66 per cent) respondents had earned
10 per cent or less of their income from cannabis cultivation. A similar proportion of growers in the
11 original countries (68 per cent overall) also reported that less than 10 per cent of their total
income came from cannabis cultivation.
New Zealand growers reported a relatively high incidence of selling drugs other than cannabis
(13 per cent), while very few Israeli growers reported doing so (1 per cent). Only a small minority of
the respondents in the original 11 countries reported selling drugs other than cannabis
(i.e. 7 per cent of the sample as a whole), although this figure was notably higher among the US
(18 per cent) and Canadian (28 per cent) respondents.
Police contact and other illegal activity
Both the New Zealand (16 per cent) and Israeli (17 per cent) growers had similar levels of contact
with the police due to their cannabis cultivation (Table VI). Overall, 15 per cent of respondents
from the 11 original countries reported they had come into contact with the police, although there
was some variation between countries (Table VI). Finnish (25 per cent), Austrian (21 per cent) and
Australian (20 per cent) growers were the most likely to report contact with the police as a result of
their cannabis cultivation.
Table V Market participation
New Zealand Israel 11 combined
What did you do with the cannabis you grew in the
last 12 months? (%)
Consume for personal use 87 99 97
Swap with other growers 30 9 26
Give away (or share) 69 51 71
Sell (includes both to cover costs and for profit) 31 27 29
Sell to cover costs of growing 25 20 23
Sell for profit 20 15 13
Keep in your possession 30 19 36
Total n 202 166 4,014
What percentage of total income came from
cultivation activities? (%)a
0-10 68 66 68
11-50 25 24 21
51-100 7 11 12
Total n 28 38 1,005
Have you sold any drugs other than cannabis or
cannabis products in the last 12 months? (%)
No 87 99 93
Yes 13 1 7
Total n 54 318 4,105
Note: aOnly those respondents reporting selling 1 per cent or more of their crop (whether for profit or for covering costs) were included in this analysis































There are limitations related to the research design that are important to consider when interpreting
the findings. The online survey samples are not representative of broader populations of cannabis
growers in any of the participating countries. There is likely to be a bias towards smaller scale
cannabis growers who are less concerned about the possibility of criminal justice repercussions
from being caught growing cannabis. The fact that the survey is online also suggests a bias
towards demographic groups who utilise and engage with the internet. A range of recruitment
strategies were employed to attempt to minimise these sampling limitations, including the use of a
wide variety of recruitment avenues, and by not offering any financial incentive to complete the
survey (Barratt et al., 2015). Different recruitment strategies were employed in each country, which
further complicates comparisons across countries. Yet, it is important to note that many of
the limitations of online purposive sampling are broadly similar to “traditional” face-to-face purposive
methods of studying hidden populations (Barratt and Lenton, 2015). Furthermore, representative
sampling designs are prohibitively expensive when studying very small hidden populations,
like cannabis cultivators (Barratt et al., 2015). The official view of illegal cannabis cultivation is almost
entirely based on law enforcement data, which has its own significant biases. Consequently, we feel
that our findings provide a valuable alternative picture of small-scale cannabis cultivation.
The samples of New Zealand and Israeli cannabis growers largely support the overall picture of
small-scale cannabis cultivation found from the previous surveys of the 11 original countries (Potter
et al., 2015). The respondents were largely small-scale cultivators growing cannabis for personal
use and sharing with others. While approximately three out of ten of the New Zealand and Israeli
growers had sold cannabis, the majority reported doing so only to cover the costs of cultivation.
Two-thirds received 10 per cent or less of their income from cannabis cultivation. The median
number of cannabis plants in the crops of New Zealand and Israeli growers was five and two,
respectively. The majority of the New Zealand and Israeli respondents were employed, with only
around 10 per cent receiving social welfare benefits. These findings support the understanding of
small-scale cannabis growing as primarily a means of “social supply” of cannabis (Potter, 2010;
Hough et al., 2003; Hakkarainen, Frank, Perälä and Dahl, 2011; Frank et al., 2011).
In New Zealand, around half of the respondents reported growing cannabis for their own or others’
medical needs, whereas a smaller proportion reported growing for medical purposes in Israel. This
may reflect the limited official access to medical cannabis in New Zealand compared to the
established medical cannabis programme in Israel. It also may also merely be a strategy to divert
stigmatisation by claiming cannabis cultivation and use for medical reasons. Overall, providing
cannabis for medicinal reasons was one of the leading reasons for growing cannabis given by
respondents from all the countries (see Hakkarainen et al., 2015; Hakkarainen et al., 2017).
More research is needed on how medical cannabis policies may influence the motivation for small-
scale cannabis growing.
Finally, 16 per cent of the New Zealand and 17 per cent of Israeli growers had come into contact with
the police because of their cannabis cultivation, similar to the levels reported in the original
11 countries. This confirms that the authorities in these countries are actively involved in enforcing the
prohibition of cannabis cultivation, and puts growers at risk from the negative impacts of a criminal
conviction, including reduced employment, travel and housing opportunities. In New Zealand,
cannabis growers also face the risk of asset forfeiture, including landwhere cannabis plants are found
and assets deemed to be purchased with the proceeds from selling cannabis (Csete et al., 2016).
Table VI Police contact related to cannabis cultivation
New Zealand Israel 11 combined
Have you ever come into contact with the police because of
your cannabis growing? (%a)
No 84 83 86
Yes 16 17 15
Total
n 148 316 6,297
Note: aThe percentage may not total 100 due to rounding
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